A clinical study on growth factor fibrin concentration to promote the regeneration of jaw tissue

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040697

Enrollment

Unknown

Registered

2020-12-08

Start date

2020-12-15

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

jaw defects

Interventions

CGF Group:CGF cavity filling

Control group:Common biological bone material

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Patients with fracture failure or delayed healing; 2) Bone defect caused by fracture; 3) Bone defects or cavities caused by mandibular cysts, jaw tumors or tumor-like lesions, impacted teeth and multiple teeth.

Exclusion criteria

Exclusion criteria: Patients with poor systemic conditions or severe systemic diseases that cannot tolerate surgery, acute and chronic inflammation of local tissues, malignant tumors, etc

Design outcomes

Primary

Measure	Time frame
Serum bone alkaline phosphatase;osteocalcin;Bone mineral density;Levels of growth factors;	—

Countries

China

Contacts

Public ContactFang Dongdong

Second Affiliated Hospital of Anhui Medical University

fangdongdong82@163.com+86 13956047259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026